Cullinan Oncology, Inc. (CGEM) Misses Q1 EPS by 44c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q1 EPS of ($1.42), $0.44 worse than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge